Filtros de búsqueda

Lista de obras de

"The Second Time is Sweeter After All".

artículo científico publicado en 2017

A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study

artículo científico publicado en 2016

A computer-based system for management of clinical and laboratory data of a comprehensive sickle cell center.

artículo científico publicado en 1974

A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia

artículo científico publicado en 2009

A neoplasm with FIP1L1-PDGFRA fusion presenting as pediatric T-cell lymphoblastic leukemia/lymphoma without eosinophilia.

artículo científico publicado en 2017

A pharmacoeconomic analysis of pegaspargase versus native Escherichia coli L-asparaginase for the treatment of children with standard-risk, acute lymphoblastic leukemia: the Children's Cancer Group study (CCG-1962)

scientific article published on 01 March 2002

A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from TACL consortium

artículo científico publicado en 2018

A phase I study of EZN-3042, a novel survivin messenger ribonucleic acid (mRNA) antagonist, administered in combination with chemotherapy in children with relapsed acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childho

artículo científico publicado en 2014

A phase I study of carboplatin in children with acute leukemia in bone marrow relapse. A report from the Childrens Cancer Group

artículo científico publicado en 1993

A phase II study of carboplatin as a treatment for children with acute leukemia recurring in bone marrow: a report of the Children's Cancer Group

scientific article published on 01 July 1997

A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study

artículo científico publicado en 2002

A remembrance: James B. Nachman 1948–2011 ⬇️

artículo científico publicado el 1 de octubre de 2011

A retrieval system for a library of pathology reports, slides and kodachromes

artículo científico publicado en 1972

ABT-751 in Relapsed Childhood Acute Lymphoblastic Leukemia ⬇️

artículo científico publicado el 1 de octubre de 2012

ALL and osteonecrosis

artículo científico publicado en 2015

Abnormalities of chromosome bands 13q12 to 13q14 in childhood acute lymphoblastic leukemia

scientific article published on 01 November 2000

Abnormalities of chromosome bands 15q13-15 in childhood acute lymphoblastic leukemia

artículo científico publicado en 2002

Acute leukemia in children.

artículo científico publicado en 1995

Allergic reactions and antiasparaginase antibodies in children with high-risk acute lymphoblastic leukemia: A children's oncology group report

artículo científico publicado en 2015

Altered patterns of T cell cytokine production induced by relapsed pre-B ALL cells.

artículo científico publicado en 2003

An adjustment for patient heterogeneity in the design of two-stage phase II trials

artículo científico publicado en 2009

An automated parsing routine for diagnostic statements of surgical pathology reports

artículo científico publicado el 1 de julio de 1971

Anaphylactic reaction to etoposide phosphate ⬇️

artículo científico publicado el 22 de abril de 2012

Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961.

artículo científico publicado en 2004

Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: a Children's Oncology Group study (CCG-1941).

artículo científico publicado en 2006

Association of delivered drug dose and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features

scientific article published on 01 January 1991

Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report fr

artículo científico publicado en 1997

Bone marrow leukemic progenitor cell content in pediatric T-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse

scientific article published on 01 January 2001

Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.

artículo científico publicado en 2006

Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study ⬇️

artículo científico publicado el 31 de mayo de 2012

Bortezomib, Dexamethasone, Mitoxantrone, and Vinorelbine (BDMV): An Active Reinduction Regimen for Children With Relapsed Acute Lymphoblastic Leukemia and Asparaginase Intolerance

artículo científico publicado en 2016

CD19-antigen specific nanoscale liposomal formulation of a SYK P-site inhibitor causes apoptotic destruction of human B-precursor leukemia cells

artículo científico publicado en 2014

CD22 Exon 12 deletion is a characteristic genetic defect of therapy‐refractory clones in paediatric acute lymphoblastic leukaemia ⬇️

artículo científico publicado el 21 de octubre de 2011

CNS-Directed Therapy for Childhood Acute Lymphoblastic Leukemia: Childhood ALL Collaborative Group Overview of 43 Randomized Trials ⬇️

artículo científico publicado el 1 de mayo de 2003

Changes of amino acid serum levels in pediatric patients with higher-risk acute lymphoblastic leukemia (CCG-1961).

artículo científico publicado en 2004

Childhood acute lymphoblastic leukaemia and relapse

artículo científico publicado en 2005

Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study

artículo científico publicado en 2005

Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study

artículo científico publicado en 1997

Clinical significance of deletions of chromosome arm 6q in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group

artículo científico publicado en 2000

Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group ⬇️

artículo científico publicado el 1 de febrero de 1998

Comparative Toxicity by Sex Among Children Treated for Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

artículo científico publicado en 2015

Constitutive function of the Ikaros transcription factor in primary leukemia cells from pediatric newly diagnosed high-risk and relapsed B-precursor ALL patients

artículo científico publicado en 2013

Continuous Infusion of 5-Azacytidine as Induction for Acute Nonlymphocytic Leukemia in Patients with Previous Exposure to 5-Azacytidine ⬇️

artículo científico publicado el 1 de enero de 1983

Craniospinal irradiation for acute lymphoblastic leukemia with central nervous system disease at diagnosis: a report from the Children's Cancer Group

scientific article published on 01 August 1996

Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group

scientific article published on 01 February 1996

Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG-1961).

artículo científico publicado en 2004

Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children's Cancer Group

artículo científico publicado en 2004

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

artículo científico publicado en 2003

Duration of hospitalization as a measure of cost on Children's Cancer Group acute lymphoblastic leukemia studies

artículo científico publicado en 2001

Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

artículo científico publicado en 2007

Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial ⬇️

artículo científico publicado el 15 de agosto de 2012

End of induction minimal residual disease alone is not a useful determinant for risk stratified therapy in pediatric T-cell acute lymphoblastic leukemia

artículo científico publicado en 2015

Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

artículo científico publicado en 2011

Expression of BCR-ABL, E2A-PBX1, and MLL-AF4 Fusion Transcripts in Newly Diagnosed Children with Acute Lymphoblastic Leukemia: A Children's Cancer Group Initiative ⬇️

artículo científico publicado el 1 de junio de 1997

Expression of TEL-AML1 Fusion Transcripts and Response to Induction Therapy in Standard Risk Acute Lymphoblastic Leukemia

scientific article published on 01 June 2001

Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia

artículo científico publicado en 1999

Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study

artículo científico publicado en 2008

Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children's Oncology Group

artículo científico publicado en 2015

First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases.

artículo científico publicado en 2018

Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group ⬇️

artículo científico publicado el 1 de abril de 1998

From where do clinical trials come?

artículo científico publicado en 2002

Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia

artículo científico publicado en 1999

Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia

artículo científico publicado en 2002

High-resolution melting curve analysis, a rapid and affordable method for mutation analysis in childhood acute myeloid leukemia

artículo científico publicado en 2014

Historical Controls?

artículo científico publicado en 2017

Impact on survival and toxicity by duration of weight extremes during treatment for pediatric acute lymphoblastic leukemia: A report from the Children's Oncology Group.

artículo científico publicado en 2014

Importance of the day 7 bone marrow biopsy as a prognostic measure of the outcome in children with acute lymphoblastic leukemia

artículo científico publicado en 1997

Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group ⬇️

artículo científico publicado el 12 de marzo de 2012

Improved clinical outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: a Children's Cancer Group Study

scientific article published on 01 December 1996

Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group

artículo científico publicado en 1986

Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study

artículo científico publicado en 2009

Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106

scientific article published on 01 November 1993

Improving access to novel agents for childhood leukemia

artículo científico publicado en 2015

Increased post-induction intensification improves outcome in children and adolescents with a markedly elevated white blood cell count (≥200 × 10(9) /l) with T cell acute lymphoblastic leukaemia but not B cell disease: a report from the Children's On

artículo científico publicado en 2014

Intensification of Therapy for Children With Lower-Risk Acute Lymphoblastic Leukemia: Long-Term Follow-Up of Patients Treated on Children’s Cancer Group Trial 1881 ⬇️

artículo científico publicado el 1 de mayo de 2003

Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study Group

artículo científico publicado en 1988

Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic l

artículo científico publicado en 2006

James B. Nachman, 1948 to 2011: a remembrance

artículo científico publicado en 2011

Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031.

artículo científico publicado en 2014

Long-term results of large prospective trials in childhood acute lymphoblastic leukemia

scientific article published on 01 December 2000

Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report

artículo científico publicado en 2009

Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983.

artículo científico publicado en 2002

Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952

artículo científico publicado en 2005

Mercaptopurine in childhood acute lymphoblastic leukaemia

artículo científico publicado en 2017

Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia

scientific article published on 24 May 2018

Nanoscale liposomal formulation of a SYK P-site inhibitor against B-precursor leukemia ⬇️

artículo científico publicado el 8 de abril de 2013

No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities

artículo científico publicado en 2005

Obesity and outcome in pediatric acute lymphoblastic leukemia

artículo científico publicado en 2007

Oligoclonality and new agent evaluation in acute lymphoblastic leukaemia

artículo científico publicado en 2016

Once upon a time--a personal view on episodes in leukemia research in Germany, and beyond ⬇️

artículo científico publicado el 22 de mayo de 2013

Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial

artículo científico publicado en 2010

Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group study CCG-1952.

artículo científico publicado en 2007

Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study

artículo científico publicado en 2010

Outcome of Children with Standard-Risk T-Lineage Acute Lymphoblastic Leukemia--Comparison among Different Treatment Strategies

artículo científico publicado en 2015

Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study

artículo científico publicado en 2009

Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region

artículo científico publicado en 2002

Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia

scientific article published on 01 April 2000

Outcomes after induction failure in childhood acute lymphoblastic leukemia

artículo científico publicado en 2012

POLARS: A pathology on-line logging and reporting system ⬇️

artículo científico publicado el 1 de febrero de 1974

Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia ⬇️

artículo científico publicado el 3 de octubre de 2011

Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia (TACL) consortium

artículo científico publicado en 2010

Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia

artículo científico publicado en 2006

Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia

artículo científico publicado en 2009

Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group

artículo científico publicado en 2005

Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from Children's Oncology Group Study AALL0031

artículo científico publicado en 2014

Ponte di Legno Working Group: statement on the right of children with leukemia to have full access to essential treatment and report on the Sixth International Childhood Acute Lymphoblastic Leukemia Workshop

artículo científico publicado en 2004

Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy

artículo científico publicado en 1999

Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer

artículo científico publicado en 2010

Population pharmacokinetics of clofarabine, a second-generation nucleoside analog, in pediatric patients with acute leukemia

artículo científico publicado en 2004

Postrelapse survival in childhood acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group ⬇️

artículo científico publicado el 30 de diciembre de 2010

Preponderant mitotic activity of nonleukemic cells plays an important role in failures to detect abnormal clone in childhood acute lymphoblastic leukemia

artículo científico publicado en 2003

Profile of a dictionary compiled from scanning over one million words of surgical pathology narrative text

scientific article published on 01 August 1980

Prognostic Significance of B-Lineage Leukemic Cell Growth in SCID Mice: A Children's Cancer Group Study ⬇️

artículo científico publicado el 1 de agosto de 1998

Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes)

artículo científico publicado en 2000

Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients

artículo científico publicado en 2009

RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia.

artículo científico publicado en 2004

Racial and ethnic differences in survival of children with acute lymphoblastic leukemia

artículo científico publicado en 2002

Recent advances in acute lymphoblastic leukemia in children and adolescents: an expert panel discussion

artículo científico

Redefining treatment failure for pediatric acute leukemia in the era of minimal residual disease testing

artículo científico publicado en 2017

Reduced folate carrier and dihydrofolate reductase expression in acute lymphocytic leukemia may predict outcome: a Children's Cancer Group Study

artículo científico publicado en 2003

Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected]

artículo científico publicado en 2008

Relapsed acute lymphoblastic leukemia: current status and future opportunities

artículo científico publicado en 2008

Remission is good - relapse is bad.

artículo científico publicado en 2018

Reply: T-Cell Acute Lymphoblastic Leukemia, Minimal Residual Disease, and Lymphocyte Recovery

artículo científico publicado en 2016

Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group ⬇️

artículo científico publicado el 1 de marzo de 1998

Response to Donadieu and Hill "Clinical trials in childhood acute lymphoblastic leukemia: a common prognostic classification and a common induction therapy are now warranted".

artículo científico publicado en 2002

Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).

artículo científico publicado en 2006

Role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review

artículo científico

Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome

artículo científico publicado en 2004

Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia

artículo científico publicado en 2007

Statement by members of the Ponte di Legno Group on the right of children to have full access to essential treatment for acute lymphoblastic leukemia

scientific article published on 01 August 2004

Statement by members of the Ponte di Legno group on the right of children with leukemia to have full access to essential treatment for acute lymphoblastic leukemia

artículo científico publicado en 2005

Subcutaneous Panniculitis-like T-cell lymphoma in two pediatric patients: an HIV-positive adolescent and a 4-month-old infant

artículo científico publicado el 23 de octubre de 2012

Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse--the Children's Cancer Group Experience

artículo científico publicado en 1998

Ten-year survival of children with acute lymphoblastic leukemia: a report from the Children's Oncology Group

artículo científico publicado en 2008

The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Pediatric Acute Lymphoblastic Leukemia: Update of the 2005 Evidence-Based Review ⬇️

artículo científico publicado el 7 de abril de 2012

The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemia

artículo científico publicado en 1988

The principle and practice of reinduction therapy (in ALL): repetita iuvant! ⬇️

artículo científico publicado el 22 de mayo de 2013

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review.

artículo científico publicado en 2006

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based review

artículo científico publicado en 2005

The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the Childrens Cancer Group

artículo científico publicado en 1993

The use of glucocorticoids in acute lymphoblastic leukemia of childhood. Molecular, cellular, and clinical considerations.

artículo científico publicado en 1995

Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL): Overview and introduction to the proceedings of the 2016 TACL investigator meeting

artículo científico publicado en 2017

Tibial stress fracture mimicking neuroblastoma metastasis in two young children ⬇️

artículo científico publicado el 1 de mayo de 1995

Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conference

artículo científico publicado en 2010

Treating refractory leukemias in childhood, role of clofarabine

artículo científico publicado en 2008

Treatment adherence and 6-mercaptopurine metabolites

artículo científico publicado en 2006

Treatment of Human B-Cell Precursor Leukemia in SCID Mice by Using a Combination of the Anti-CD19 Immunotoxin B43-PAP with the Standard Chemotherapeutic Drugs Vincristine, Methylprednisolone, and L-Asparaginase ⬇️

artículo científico publicado el 1 de septiembre de 1998

Treatment of pediatric acute lymphoblastic leukemia: progress achieved and challenges remaining

artículo científico publicado en 2007

Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group

artículo científico publicado en 1999

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia

artículo científico publicado en 1996

What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies

artículo científico publicado en 2008

Young adults 16-21 years of age at diagnosis entered on Childrens Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Results of treatment

scientific article published on 01 May 1993

Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group

artículo científico publicado en 2009

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda